U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07435987) titled 'Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy' on Jan. 29.
Brief Summary: This prospective, non-randomised, single centre, phase I trial assesses the clinical feasibility of the use of the patient-tailored ARCHITECT applicator in locally advanced cervical cancer brachytherapy.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Locally Advanced Cervical Cancer
Uterine Carcinoma
Intervention:
DEVICE: ARCHITECT applicator
Patient-tailored, 3D-printed applicator
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Erasmus Medical Center
Information provided by (Responsible Party): ...